Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 3 JDMF, 3 Listed Suppliers

5 API Suppliers
3 JDMF
3 Listed Suppliers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

media
1 DATA COMPILATION #PharmaFlow

GLOBAL SALES INFORMATION

4 Annual Reports

globalSalesInformation
4 Annual Reports

MARKET PLACE

1 APIs

marketPlace
1 APIs

REF. STANDARDS & IMPURITIES

1 Others

otherSolutions
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

250

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 103300-74-9, Taltirelin acetate, Ceredist, Ta 0910, Ta-0910, Taltirelin [inn]

Molecular Formula

C₁₇H₂₃N₇O₅

Molecular Weight

405.4 g/mol

InChI Key

LQZAIAZUDWIVPM-SRVKXCTJSA-N

FDA UNII

DOZ62MV6A5

1 2D Structure

Taltirelin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide

2.1.2 InChI

InChI=1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1

2.1.3 InChI Key

LQZAIAZUDWIVPM-SRVKXCTJSA-N

2.1.4 Canonical SMILES

CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N

2.1.5 Isomeric SMILES

CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N

2.2 Other Identifiers

2.2.1 UNII

DOZ62MV6A5

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (1-methyl-4,5-dihydroorotyl)-histidyl-prolinamide

2. Ta 0910

3. Ta-0910

4. Taltirelin Hydrate

2.3.2 Depositor-Supplied Synonyms

1. 103300-74-9

2. Taltirelin Acetate

3. Ceredist

4. Ta 0910

5. Ta-0910

6. Taltirelin [inn]

7. Doz62mv6a5

8. (s)-n-((s)-1-((s)-2-carbamoylpyrrolidin-1-yl)-3-(1h-imidazol-4-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide

9. Ncgc00181033-01

10. (4s)-n-[(2s)-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-3-(3h-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide

11. (4s)-n-[(2s)-1-[(2s)-2-carbamoylpyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide

12. Unii-doz62mv6a5

13. Taltirelina

14. Taltireline

15. Taltirelinum

16. Ccris 8513

17. Taltirelin [mi]

18. Ta-0910, Taltirelin

19. Taltirelin [mart.]

20. (-)-n-(((s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-l-prolinamide

21. Dsstox_cid_23763

22. Dsstox_rid_80071

23. Taltirelin [who-dd]

24. Dsstox_gsid_43763

25. (1-methyl-4,5-dihydroorotyl)-histidyl-prolinamide

26. Schembl194528

27. Gtpl2143

28. Chembl2107016

29. Dtxsid0043763

30. Schembl21219549

31. Schembl22077031

32. Chebi:135653

33. Bcpp000053

34. Amy22588

35. Bcp02001

36. Hy-b0596

37. Zinc4217500

38. Tox21_112682

39. Akos015920135

40. Akos015969113

41. L-prolinamide, N-(((4s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-

42. L-prolinamide, N-((hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-l-histidyl-, (s)-

43. N-[[(4s)-hexahydro-1-methyl-2,6-dioxo-4-pyrimidinyl]carbonyl]-l-histidyl-l-prolinamide

44. Ncgc00381723-02

45. Ac-23956

46. Cas-103300-74-9

47. 300t749

48. J-000925

49. Q7680336

50. (1-methyl-(s)-4,5-dihydroorotyl)-l-histidyl-l-prolinamide

51. 1-methyl-(s)-4,5-dihydroorotyl-l-histidyl-l-prolinamide

52. Methyl5-(propan-2-yl)-1,2-oxazole-3-carboxylate

53. N-{[(4s)-1-methyl-2,6-dioxohexahydropyrimidin-4-yl]carbonyl}-l-histidyl-l-prolinamide

54. (s)-n-((s)-1-((s)-2-carbamoylpyrrolidin-1-yl)-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxamide

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₂₃N₇O₅
Molecular Weight	405.4 g/mol
XLogP3	-3
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	6
Exact Mass	405.17606686 g/mol
Monoisotopic Mass	405.17606686 g/mol
Topological Polar Surface Area	171 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	714
Isotope Atom Count	0
Defined Atom Stereocenter Count	3
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Nootropic Agents

Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)

API SUPPLIERS